Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields

Post date May 17, 2022 — 09:30 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Risen Oriental: The company has a stable customer base in the United States_ Oriental Fortune Net

May 20, 2022 — 18:00

Intelligent automatic control: the company's products can be applied to the wind and solar power industry, which has a positive effect on the company's performance

May 20, 2022 — 17:59

Oxycon (002913): Announcement on the progress of Oxycon Technology Co., Ltd. on the use of some idle self-owned funds for cash management- CFi.CN Zhongcai Network

May 20, 2022 — 17:56

Runyang Technology: The company's research and development projects are mainly the research and development of high-strength IXPE foam materials, the research and development of thermally conductive and insulating polyethylene foam materials, and the research and development of radiation cross-linked polybutylene succinate foam materials, etc.

May 20, 2022 — 17:55

[Opportunity Discovery] 11 major transportation project packages in the "14th Five-Year Plan" announced to pay attention to the relevant industry chain_ Oriental Fortune Net

May 20, 2022 — 17:54

63 A-share chips changed hands (May 20) _ Oriental Fortune Net

May 20, 2022 — 17:50

Meichen Ecology: The company has not verified the effect of CBD on preventing new crown infection

May 20, 2022 — 17:50

Jinlei shares: the company has been in a state of full production in the first quarter and April, and the capacity utilization rate is close to saturation

May 20, 2022 — 17:49

Photovoltaic concept stocks have been sought after by 6.6 billion main funds in the past three days_Oriental Fortune Network

May 20, 2022 — 17:47

Home » News » Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields